Penciclovir for the treatment of post therapeutic neuralgia
Patent 5866581 Issued on February 2, 1999. Estimated Expiration Date: June 20, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A method for the treatment of PHN in mammals, including humans, which method comprises administering an effective amount of a compound of formula (A), or a pharmaceutically acceptable salt thereof. ##STR1##
Other References
Poster from ICAAC, Oct. 11-14, 1992
Poster from ICAAC, Oct. 17-20, 1993
Wood et al., Scand. J. Infect. Dis., 23(80), pp. 53-61, 1991
Robertson et al., Br. Med. Bull., 46(1), pp. 113-123, 1990
Klenerman et al., Biomed. Pharmacother., 44(9), pp. 455-459, 1990
Schmader et al., J. Gen. Intern. Med., 4(2), pp. 83-89, 1989
McKendrick, et al., British Medical Journal, vol. 293, pp. 1529-1532 (1986)
Huff, et al., The American Journal of Medicine, vol. 85 (Suppl 2A), pp. 84-89, (1988)
Morton, et al., The New Zealand Medical Journal, vol. 102, No. 863, pp. 93-95, (1989)
Huff, et al., Journal of Medical Virology, Supplement 1, pp. 93-96 (1993)
Wood, et al., The New England Journal of Medicine, vol. 330, pp. 896-900, (1994)
Beutner and The International Valaciclovir Zoster Study Group, Abstract (1994)
Wood, et al., Infection 15, Suppl. 1, pp. S9-S13, (1987)
Harding, Journal of Medical Virology, Suppl. 1, pp. 97-101 (1993)
Crooks, et al., Scand J. Infect, Suppl. 78, pp. 64-70 (1991)
McKendrick, et al., British Medical Journal, 298:431 (1988